Spyros Papapetropoulos - Jul 1, 2024 Form 3 Insider Report for BIONOMICS LIMITED/FI (BNOX)

Role
Chief Executive Officer, Director
Signature
/s/ Spyridon Papapetropoulos
Stock symbol
BNOX
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
3
Date filed
7/8/2024, 06:10 AM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BNOX Ordinary Shares 6M Jul 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 6.77M $0.03 Direct
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F2
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F3
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F4
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F5
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F6
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F7
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F8
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F9
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F10
holding BNOX Option (right to buy) Jul 1, 2024 Ordinary Shares 1.69M $0.03 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Some Ordinary Shares are represented by American Depositary Shares.
F2 Granted on December 16, 2022. Vesting to occur on September 16, 2024, provided Mr. Papapetropoulos is still employed on such date.
F3 Granted on December 16, 2022. Vesting to occur on December 16, 2024, provided Mr. Papapetropoulos is still employed on such date.
F4 Granted on December 16, 2022. Vesting to occur on March 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F5 Granted on December 16, 2022. Vesting to occur on June 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F6 Granted on December 16, 2022. Vesting to occur on September 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F7 Granted on December 16, 2022. Vesting to occur on December 16, 2025, provided Mr. Papapetropoulos is still employed on such date.
F8 Granted on December 16, 2022. Vesting to occur on March 16, 2026, provided Mr. Papapetropoulos is still employed on such date.
F9 Granted on December 16, 2022. Vesting to occur on June 16, 2026, provided Mr. Papapetropoulos is still employed on such date.
F10 Granted on December 16, 2022. Vesting to occur on September 16, 2026, provided Mr. Papapetropoulos is still employed on such date.
F11 Granted on December 16, 2022. Vesting to occur on December 16, 2026, provided Mr. Papapetropoulos is still employed on such date.